γδ T cells in colorectal and liver cancer
Gamma-delta immune cells bypass traditional barriers to attack liver and colorectal cancers, promising broader immunotherapy access.
This Nature Reviews article synthesizes the biology of γδ T cells in colorectal and liver cancer, detailing their dual antitumor and protumorigenic roles and the current state of clinical development. Given their HLA-independent cytotoxicity, γδ T cells represent a promising immunotherapy platform particularly relevant for patients with heterogeneous HLA profiles.
What the study was
- Study design
- Narrative review
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Nature Reviews Gastroenterology & Hepatology
Why it surfaced
Nature Reviews; comprehensive γδ T cell immunotherapy review; high-impact journal; relevant to CAR-T/novel therapeutics pipeline.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.